VANI VIVANI MEDICAL INC revenue, earnings and financials
For the quarter ended June 30, 2026, VIVANI MEDICAL INC reported revenue of n/a, net income of −$6.37M and diluted EPS of −$0.07; for the fiscal year ended December 2025 revenue was $0.
VANI annual revenue and earnings
- Fiscal year ended Dec 2025: revenue $0, gross profit n/a, operating income −$27.6M, net income $26.6M (margin n/a), EPS −$0.43
- Fiscal year ended Dec 2024: revenue $0, gross profit n/a, operating income −$24.7M, net income $23.5M (margin n/a), EPS −$0.43
- Fiscal year ended Dec 2023: revenue n/a, gross profit n/a, operating income −$27.0M, net income $25.7M (margin n/a), EPS −$0.50
- Fiscal year ended Dec 2022: revenue n/a, gross profit n/a, operating income −$21.2M, net income −$13.9M (margin n/a), EPS n/a
VANI quarterly revenue and earnings
- Quarter ended Jun 30, 2026: revenue n/a, net income −$6.37M, EPS −$0.07
- Quarter ended Mar 31, 2026: revenue n/a, net income −$6.78M, EPS −$0.08
- Quarter ended Dec 31, 2025 (from the annual report): revenue n/a, net income $46.6M, EPS −$0.09
- Quarter ended Sep 30, 2025: revenue n/a, net income −$6.53M, EPS −$0.11
- Quarter ended Jun 30, 2025: revenue n/a, net income −$7.14M, EPS −$0.12
- Quarter ended Mar 31, 2025: revenue $0, net income −$6.30M, EPS −$0.11
- Quarter ended Dec 31, 2024 (from the annual report): revenue n/a, net income $40.9M, EPS −$0.10
- Quarter ended Sep 30, 2024: revenue n/a, net income −$6.04M, EPS −$0.11
- Quarter ended Jun 30, 2024: revenue n/a, net income −$5.36M, EPS −$0.10
- Quarter ended Mar 31, 2024: revenue n/a, net income −$6.04M, EPS −$0.12
- Quarter ended Dec 31, 2023 (from the annual report): revenue n/a, net income $45.3M, EPS n/a
- Quarter ended Sep 30, 2023: revenue n/a, net income −$6.78M, EPS −$0.13
- Quarter ended Jun 30, 2023: revenue n/a, net income −$6.53M, EPS −$0.13
- Quarter ended Mar 31, 2023: revenue n/a, net income −$6.32M, EPS n/a
- Quarter ended Dec 31, 2022 (from the annual report): revenue n/a, net income −$7.28M, EPS n/a
- Quarter ended Sep 30, 2022: revenue n/a, net income $1.42M, EPS $0.04
- Quarter ended Jun 30, 2022: revenue n/a, net income −$4.10M, EPS n/a
- Quarter ended Mar 31, 2022: revenue n/a, net income −$3.92M, EPS n/a
- Quarter ended Dec 31, 2021: revenue n/a, net income −$1.28M, EPS −$0.03
- Quarter ended Sep 30, 2021: revenue n/a, net income −$3.49M, EPS −$0.10
VANI cash flow, buybacks and dividends
- Fiscal year ended Dec 2025: operating cash flow −$24.3M, share buybacks n/a
- Fiscal year ended Dec 2024: operating cash flow −$20.8M, share buybacks n/a
- Fiscal year ended Dec 2023: operating cash flow −$23.7M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$18.8M, share buybacks n/a
VANI balance sheet
- Jun 30, 2026: cash $19.9M, total assets $41.6M, total liabilities $22.7M, shareholders' equity $19.0M
- Mar 31, 2026: cash $19.7M, total assets $42.4M, total liabilities $23.3M, shareholders' equity $19.1M
- Dec 31, 2025: cash $16.2M, total assets $39.4M, total liabilities $23.7M, shareholders' equity $15.7M
- Sep 30, 2025: cash $2.63M, total assets $25.0M, total liabilities $23.7M, shareholders' equity $1.31M
- Jun 30, 2025: cash $6.79M, total assets $28.9M, total liabilities $24.0M, shareholders' equity $4.91M
- Mar 31, 2025: cash $13.0M, total assets $35.5M, total liabilities $23.8M, shareholders' equity $11.6M
- Dec 31, 2024: cash $18.4M, total assets $41.6M, total liabilities $24.0M, shareholders' equity $17.6M
- Sep 30, 2024: cash $19.6M, total assets $42.9M, total liabilities $24.6M, shareholders' equity $18.3M
What is VANI's revenue?
VIVANI MEDICAL INC reported $0 of revenue for the fiscal year ended December 2025.
Is VANI profitable?
Yes. VIVANI MEDICAL INC earned $26.9M over the last four quarters.
What is VANI's EPS?
Diluted earnings per share over the last four quarters were −$0.35; −$0.07 in the latest quarter.